Early Identification of Markers in Alzheimer's Families / ALFA
NCT02485730 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 419
Last updated 2025-05-31
Summary
The ALFA study is a long term, prospective, observational study of AD patients' adult children aimed at studying and characterizing key physio-pathological features of the preclinical phase of AD.
Conditions
Sponsors & Collaborators
-
Obra Social La Caixa, Spain
collaborator UNKNOWN -
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
lead OTHER
Principal Investigators
-
Jose Luis Molinuevo, MD, PhD · Scientific Director
Eligibility
- Min Age
- 45 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-25
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Natural History and Disease Progression Biomarkers of Multiple System Atrophy
NCT04229173 ·Status: COMPLETED ·Phase: NA
-
Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
NCT01876459 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
NCT07007208 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study
NCT01773915 ·Status: UNKNOWN
-
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850 ·Status: RECRUITING
-
Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study
NCT04992975 ·Status: RECRUITING
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Understanding Motor Function in Stroke Patients and Their Functional Brain Reorganization Using Ultra High-field MRI
NCT07339813 ·Status: RECRUITING ·Phase: NA
-
Neuroinflammation and Cognitive Decline in Alzheimer Disease
NCT02377206 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
New Imaging Biomarkers Predictive of MA Progression
NCT05939362 ·Status: RECRUITING ·Phase: NA
-
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
NCT03863041 ·Status: COMPLETED ·Phase: NA
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
NCT02850146 ·Status: COMPLETED ·Phase: PHASE1
-
β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline
NCT04935372 ·Status: ACTIVE_NOT_RECRUITING
-
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
NCT06099587 ·Status: RECRUITING ·Phase: NA
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid
NCT02946710 ·Status: COMPLETED
-
IGF and Other Neurotrophic Factors in Patients With Dementia
NCT02271750 ·Status: COMPLETED
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA
-
Study of Iron Accumulation Measured in MRI in Non-pathological Aging
NCT04659824 ·Status: RECRUITING
-
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
NCT03129269 ·Status: COMPLETED ·Phase: NA
-
Novel Dementia Biomarkers
NCT04427436 ·Status: UNKNOWN
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging
NCT01815112 ·Status: TERMINATED ·Phase: NA
-
Optimization and Harmonization of Advanced MRI Sequences
NCT06217237 ·Status: COMPLETED